Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2

The synthesis and design guided by SAR and SPR studies of novel quinazoline derivatives as MCHR1 antagonists are described. Compound 8 (DRL-21816) has emerged as a lead optimized candidate with a good cardiovascular safety window.